- Home
- NERV vs HCTI Comparison
NERV vs HCTI Comparison
Compare NERV & HCTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- HCTI
- Stock Information
- Founded
- NERV 2007
- HCTI 2020
- Country
- NERV United States
- HCTI United States
- Employees
- NERV N/A
- HCTI N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- HCTI Retail: Computer Software & Peripheral Equipment
- Sector
- NERV Health Care
- HCTI Technology
- Exchange
- NERV Nasdaq
- HCTI Nasdaq
- Market Cap
- NERV 12.6M
- HCTI 13.5M
- IPO Year
- NERV 2014
- HCTI 2021
- Fundamental
- Price
- NERV $1.73
- HCTI $0.03
- Analyst Decision
- NERV Hold
- HCTI
- Analyst Count
- NERV 1
- HCTI 0
- Target Price
- NERV $5.00
- HCTI N/A
- AVG Volume (30 Days)
- NERV 12.1K
- HCTI 711.8M
- Earning Date
- NERV 08-05-2025
- HCTI 08-18-2025
- Dividend Yield
- NERV N/A
- HCTI N/A
- EPS Growth
- NERV N/A
- HCTI N/A
- EPS
- NERV 0.83
- HCTI N/A
- Revenue
- NERV N/A
- HCTI $11,291,000.00
- Revenue This Year
- NERV N/A
- HCTI N/A
- Revenue Next Year
- NERV N/A
- HCTI N/A
- P/E Ratio
- NERV $2.06
- HCTI N/A
- Revenue Growth
- NERV N/A
- HCTI N/A
- 52 Week Low
- NERV $1.15
- HCTI $0.01
- 52 Week High
- NERV $3.50
- HCTI $1.90
- Technical
- Relative Strength Index (RSI)
- NERV 50.22
- HCTI 42.03
- Support Level
- NERV $1.57
- HCTI $0.02
- Resistance Level
- NERV $1.88
- HCTI $0.03
- Average True Range (ATR)
- NERV 0.09
- HCTI 0.01
- MACD
- NERV -0.02
- HCTI 0.01
- Stochastic Oscillator
- NERV 52.03
- HCTI 40.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.